Statewide
State of Nebraska
The current listed document is more than 24 months old and may be outdated.
Drugs and doses53
A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride, Calcium Gluconate8
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 15 mg/kg | IV | not captured | standing | page 168 |
| Other | adult | 650 mg | IV | not captured | standing | page 168 |
| Other | peds | 10 mg/kg | PO | not captured | standing | page 168 |
| Mild to moderate pain | adult | 325–1000 mg | PO | not captured | standing | pages 25, 87, 168 |
| Mild to moderate pain | adult | 650–1000 mg | IV/IO | not captured | standing | pages 25, 87, 168 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | pages 25, 87, 168 |
| Mild to moderate pain | peds | 15 mg/kg | IV/IO | not captured | standing | pages 25, 87, 168 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 6 mg | IV/IO | not captured | standing | pages 37, 169 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 37, 169 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 65, 111, 170 |
| Asthma / bronchospasm | adult | 4 puff | MDI | not captured | standing | pages 65, 111, 170 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | pages 65, 111, 170 |
| Other | adult | 2 puff | MDI | not captured | standing | page 49 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 170 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV/IO | not captured | standing | page 35 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | pages 91, 92 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | page 171 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 31, 91, 171 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 31, 91, 171 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 31, 91, 171 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 31, 91, 171 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 324 mg | PO | not captured | standing | pages 43, 172 |
| Other | adult | 324 mg | PO | not captured | standing | page 172 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 41, 99, 173 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 41, 99, 173 |
| Organophosphate poisoning | adult | 2 mg | IV/IO | not captured | standing | pages 151, 173 |
| Organophosphate poisoning | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 151, 173 |
| Other | adult | 1 mg | IV/IO | not captured | standing | page 173 |
| Other | adult | 2 mg | IV/IO/IM | not captured | standing | pages 151, 152 |
| Other | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 173 |
| Other | peds | 0.05 mg/kg | IV/IO/IM | not captured | standing | pages 151, 152 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 g | IV/IO | not captured | standing | pages 109, 131, 174 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | pages 109, 131, 174 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 131 |
| Other | adult | 1000 mg | IV | not captured | standing | page 174 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 109 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 131 |
| Other | peds | 20 mg/kg | IV | not captured | standing | page 174 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | pages 33, 125, 175 |
| Hyperkalemia | peds | 100 mg/kg | IV/IO | not captured | standing | pages 33, 125, 175 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 125 |
| Other | adult | 1000 mg | IV/IO | not captured | standing | page 175 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 125 |
| Other | peds | 60–100 mg/kg | IV/IO | not captured | standing | page 175 |
D–F Dexamethasone, Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dopamine, Droperidol, Epinephrine, Etomidate, Fentanyl10
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.6 mg/kg | IV/IO | not captured | standing | pages 49, 101 |
| Allergic reaction | peds | 0.6 mg/kg | IV/IO | not captured | standing | pages 49, 101 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | pages 55, 105 |
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | pages 55, 105, 176 |
| Hypoglycemia | peds | 0.5 g/kg | IV/IO | not captured | standing | pages 55, 105, 176 |
| Hypoglycemia | peds | 15 g | PO | not captured | standing | pages 55, 105 |
| Other | adult | 12.5 g | IV/IO | not captured | standing | page 176 |
| Other | adult | 25 g | IV/IO | not captured | standing | page 176 |
| Other | adult | 25 g | IV/IO | not captured | standing | pages 55, 105 |
| Other | peds | 0.5 g/kg | IV/IO | not captured | standing | page 176 |
| Other | peds | 1 g/kg | IV/IO | not captured | standing | page 176 |
| Other | peds | 5 mL | IV/IO | not captured | standing | page 77 |
| Other | peds | 25 g | IV/IO | not captured | standing | pages 55, 105 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 0.3 mg/kg | PR | not captured | standing | pages 113, 178 |
| Seizure | adult | 2 mg | IV/IO | not captured | standing | page 178 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 178 |
| Seizure | peds | 0.2 mg/kg | PR | not captured | standing | page 178 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.25 mg/kg | IV | not captured | standing | page 179 |
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV/IO | not captured | standing | pages 37, 179 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 25 mg | IV | not captured | standing | page 11 |
| Agitation | adult | 50 mg | IM | not captured | standing | page 11 |
| Allergic reaction | adult | 25–50 mg | IV/IO | not captured | standing | pages 49, 101 |
| Allergic reaction | peds | 1 mg/kg | IV/IO | not captured | standing | pages 49, 101 |
| Dystonic reaction | adult | 50 mg | IV/IO/IM | not captured | standing | pages 12, 72 |
| Dystonic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 12, 72 |
| Other | adult | 25 mg | IV/IO/IM | not captured | standing | page 180 |
| Other | adult | 50 mg | IV | not captured | standing | page 200 |
| Other | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 101 |
| Other | peds | 1 mg/kg | IV | not captured | standing | page 200 |
| Other | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 180 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 5–20 mcg/kg | IV/IO | not captured | standing | pages 35, 36, 41, 42, 181 |
| Bradycardia | peds | 5–10 mcg/kg | IV/IO | not captured | standing | pages 35, 36, 41, 42, 181 |
| Hypotension / shock | adult | 5–20 mcg/kg | IV/IO | not captured | standing | pages 35, 36, 61, 62, 107, 108, 181 |
| Hypotension / shock | peds | 5–10 mcg/kg | IV/IO | not captured | standing | pages 35, 36, 61, 62, 107, 108, 181 |
| Hypotension / shock | peds | 5–20 mcg/kg | IV/IO | not captured | standing | pages 107, 108 |
| Other | adult | 2–20 mcg/kg | IV/IO | not captured | standing | page 181 |
| Other | adult | 5–20 mcg/kg | IV/IO | not captured | standing | pages 35, 36 |
| Other | peds | 5–10 mcg/kg | IV/IO | not captured | standing | page 181 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV | not captured | standing | page 11 |
| Agitation | adult | 5–10 mg | IM | not captured | standing | page 11 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | pages 49, 101, 183 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | pages 49, 101, 183 |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | pages 41, 42, 185 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 31, 33, 91, 93, 184 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 31, 33, 91, 93, 184 |
| Other | adult | 0.3–0.5 mg | IM | not captured | standing | page 49 |
| Other | adult | 0.3 mg | IM | not captured | standing | pages 49, 183 |
| Other | adult | 0.3 mg | IM | not captured | standing | page 183 |
| Other | peds | 0.01 mg/kg | IM | not captured | standing | page 183 |
| Other | peds | 0.15 mg | IM | not captured | standing | pages 101, 183 |
| Other | peds | 0.5 mg | NEB | not captured | standing | page 184 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 21 |
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | pages 21, 83, 186 |
| RSI induction | peds | 0.3 mg/kg | IV/IO | not captured | standing | pages 21, 83, 186 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mcg/kg | IV/IO | not captured | standing | page 23 |
| Other | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 25 |
| Other | adult | 1 mcg/kg | IV/IO | not captured | standing | page 29 |
| Other | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 187 |
| Other | peds | 1 mcg/kg | IV/IO/IN | not captured | standing | page 87 |
| Other | peds | 1 mcg/kg | IV/IO/IN | not captured | standing | page 99 |
| Mild to moderate pain | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 25, 87 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 25, 87 |
| Post-intubation sedation | adult | 1 mcg/kg | IV/IO | not captured | standing | pages 23, 85 |
| Post-intubation sedation | peds | 1 mcg/kg | IV/IO | not captured | standing | pages 23, 85 |
G–L Glucagon, Haloperidol, Hydromorphone, Hydroxocobalamin, Ibuprofen, Ipratropium, Ketamine, Ketorolac, Labetalol, Lidocaine, Lorazepam11
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2 mg | IV/IO | not captured | standing | pages 63, 109, 188 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 2 mg | IV/IO | not captured | standing | pages 63, 109, 188 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 63, 109, 188 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 63, 109, 188 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | pages 55, 105, 188 |
| Hypoglycemia | adult | 3 mg | IN | not captured | standing | pages 55, 105, 188 |
| Hypoglycemia | peds | 0.1 mg/kg | IM | not captured | standing | pages 55, 105, 188 |
| Other | adult | 1 mg | IM | not captured | standing | pages 55, 105 |
| Other | adult | 1 mg | IM/SQ | not captured | standing | page 188 |
| Other | adult | 2 mg | IV/IO/IM | not captured | standing | page 63 |
| Other | adult | 3 mg | IN | not captured | standing | pages 55, 105 |
| Other | adult | 3 mg/kg | IV | not captured | standing | page 188 |
| Other | peds | 0.1 mg/kg | IM/SQ | not captured | standing | page 188 |
| Other | peds | 0.1 mg/kg | IM/SQ | not captured | standing | page 188 |
| Other | peds | 1 mg | IM | not captured | standing | pages 55, 105 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV | not captured | standing | page 11 |
| Agitation | adult | 5–10 mg | IM | not captured | standing | page 11 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5–1 mg | IV/IO/IM/IN | not captured | standing | page 25 |
| Other | adult | 0.5–1 mg | IV/IO | not captured | standing | page 23 |
| Other | adult | 0.5–1 mg | IV/IO/IM | not captured | standing | page 189 |
| Other | peds | 0.01 mg/kg | IV/IO/IM | not captured | standing | page 85 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 87 |
| Other | peds | 0.01 mg/kg | IV/IO/IM | not captured | standing | page 189 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | pages 149, 190 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | pages 149, 190 |
| Other | adult | 5 g | IV/IO | not captured | standing | page 149 |
| Other | adult | 5 g | IV/IO | not captured | standing | page 190 |
| Other | peds | 70 mg/kg | IV/IO | not captured | standing | page 149 |
| Other | peds | 70 mg/kg | IV/IO | not captured | standing | page 190 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 400–800 mg | PO | not captured | standing | pages 25, 87 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | pages 25, 87 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | pages 49, 65, 111, 192 |
| Asthma / bronchospasm | peds | 0.25 mg | NEB | not captured | standing | pages 49, 65, 111, 192 |
| Other | adult | 0.5 mg | NEB | not captured | standing | page 192 |
| Other | peds | 0.5 mg | NEB | not captured | standing | page 111 |
| Other | peds | 0.5 mg | NEB | not captured | standing | page 192 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 3–5 mg/kg | IM | not captured | standing | page 11 |
| Cardiac arrest | adult | 3 mg/kg | IV/IO | not captured | standing | page 29 |
| Other | adult | 0.5 mg/kg | IV/IO/IM | not captured | standing | page 193 |
| Other | adult | 3 mg/kg | IV | not captured | standing | page 193 |
| Other | adult | 3 mg/kg | IM | not captured | standing | page 193 |
| Other | peds | 0.5 mg/kg | IM/IN | not captured | standing | page 85 |
| Mild to moderate pain | adult | 0.1–0.2 mg/kg | IV/IO/IM | not captured | standing | pages 25, 87 |
| Mild to moderate pain | peds | 0.1–0.2 mg/kg | IV/IO/IM | not captured | standing | pages 25, 87 |
| Post-intubation sedation | adult | 0.5 mg/kg | IV/IO | not captured | standing | pages 23, 85 |
| Post-intubation sedation | peds | 0.5 mg/kg | IV/IO | not captured | standing | pages 23, 85 |
| RSI induction | adult | 3 mg/kg | IV/IO | not captured | standing | pages 21, 83 |
| RSI induction | peds | 2–3 mg/kg | IV/IO | not captured | standing | pages 21, 83 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 15 mg | IV/IO/IM | not captured | standing | page 194 |
| Mild to moderate pain | adult | 15–30 mg | IV/IO/IM | not captured | standing | page 25 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10–20 mg | IV | not captured | standing | pages 53, 195 |
| Other | adult | 10–20 mg | IV | not captured | standing | page 195 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | pages 32, 92 |
| Other | adult | 40 mg | IO | not captured | standing | pages 196, 242 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | pages 196, 242 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | pages 32, 92 |
| VF / pulseless VT | adult | 1.5 mg/kg | IV/IO | not captured | standing | pages 31, 91, 196 |
| VF / pulseless VT | adult | 1.5 mg/kg | IV/IO | not captured | standing | pages 31, 91, 196 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | pages 31, 91, 196 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | pages 31, 91, 196 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1–2 mg | IV/IO | not captured | standing | pages 11, 197 |
| Agitation | adult | 2 mg | IV/IO | not captured | standing | page 11 |
| Agitation | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 11, 197 |
| Hyperactive delirium | adult | 2–4 mg | IV/IO/IN | not captured | standing | page 57 |
| Other | adult | 0.05 mg/kg | IV/IO/IM | not captured | standing | page 197 |
| Other | adult | 0.5–1 mg | IV/IO/IN | not captured | standing | page 45 |
| Mild to moderate pain | adult | 1–2 mg | IV/IO/IN | not captured | standing | page 25 |
| Seizure | adult | 2 mg | IV/IO | not captured | standing | pages 67, 113 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 67, 113 |
M–O Magnesium Sulfate, Methylprednisolone, Metoclopramide, Metoprolol, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose11
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | pages 65, 111 |
| Asthma / bronchospasm | peds | 40 mg/kg | IV/IO | not captured | standing | pages 65, 111 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | page 198 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | page 198 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 198 |
| Other | adult | 2 g | IV | not captured | standing | page 12 |
| Other | adult | 4 g | IV/IO | not captured | standing | page 67 |
| Other | peds | 40 mg/kg | IV/IO | not captured | standing | page 198 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | pages 31, 39, 97, 109 |
| VF / pulseless VT | peds | 40 mg/kg | IV/IO | not captured | standing | pages 31, 39, 97, 109 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 125 mg | IV/IO | not captured | standing | pages 49, 65, 101, 111 |
| Allergic reaction | peds | 1 mg/kg | IV/IO | not captured | standing | pages 49, 65, 101, 111 |
Metoclopramide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 5–10 mg | IV/IM | not captured | standing | pages 71, 115, 200 |
| Nausea / vomiting | adult | 5–10 mg | IV/IM | not captured | standing | page 71 |
| Nausea / vomiting | peds | 0.15 mg/kg | IV/IM | not captured | standing | pages 71, 115, 200 |
| Other | adult | 10 mg | IV | not captured | standing | page 200 |
| Other | peds | 0.1–0.2 mg/kg | IV | not captured | standing | page 200 |
| Other | peds | 0.15 mg/kg | IV/IO/IM | not captured | standing | page 115 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2.5–5 mg | IV | not captured | standing | page 201 |
| Narrow-complex tachycardia | adult | 5 mg | IV/IO | not captured | standing | pages 37, 201 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV | not captured | standing | page 11 |
| Agitation | adult | 5 mg | IM | not captured | standing | page 11 |
| Other | adult | 1–2 mg | IV/IO/IM/IN | not captured | standing | page 11 |
| Other | adult | 1–2 mg | IV/IO/IN | not captured | standing | page 202 |
| Other | adult | 2 mg | IV/IO/IM | not captured | standing | pages 37, 41, 202 |
| Other | adult | 2 mg | IV/IO | not captured | standing | pages 67, 113, 202 |
| Other | adult | 2 mg | IV/IO/IN | not captured | standing | page 202 |
| Other | adult | 5 mg | IM/IN | not captured | standing | pages 67, 113 |
| Other | adult | 5–10 mg | IV/IO/IN | not captured | standing | page 202 |
| Other | peds | 0.05 mg/kg | IV/IO/IN | not captured | standing | page 202 |
| Other | peds | 0.05 mg/kg | IV/IO | not captured | standing | page 202 |
| Other | peds | 0.1–0.2 mg/kg | IV/IO/IN | not captured | standing | page 202 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 67, 113, 202 |
| Other | peds | 0.1 mg/kg | IN | not captured | standing | page 202 |
| Other | peds | 0.2 mg/kg | IM/IN | not captured | standing | pages 67, 113 |
| Other | peds | 0.3 mg/kg | IV/IO/IN | not captured | standing | page 202 |
| Post-intubation sedation | adult | 0.05 mg/kg | IV/IO/IM/IN | not captured | standing | pages 23, 85 |
| Post-intubation sedation | peds | 0.05 mg/kg | IV/IO/IM/IN | not captured | standing | pages 23, 85 |
| Seizure | adult | 2 mg | IV/IO/IM/IN | not captured | standing | page 29 |
| Seizure | adult | 2 mg | IV/IO | not captured | standing | pages 67, 113 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 67, 113 |
| Seizure | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 113 |
| Status epilepticus | adult | 2 mg | IV/IO/IN | not captured | standing | page 202 |
| Status epilepticus | peds | 0.1–0.2 mg/kg | IV/IO/IN | not captured | standing | page 202 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 23 |
| Other | adult | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 25 |
| Other | peds | 0.05 mg/kg | IV/IO | not captured | standing | page 203 |
| Other | peds | 0.05 mg/kg | IV/IO | not captured | standing | page 87 |
| Mild to moderate pain | adult | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 25, 87, 203 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 25, 87, 203 |
| Post-intubation sedation | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 23, 85, 203 |
| Post-intubation sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 23, 85, 203 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 4 mg | IV/IO/IN | not captured | standing | page 30 |
| Opioid overdose | adult | 0.1 mg/kg | IN | not captured | standing | pages 25, 87, 204 |
| Opioid overdose | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 25, 87, 204 |
| Opioid overdose | adult | 0.4–2 mg | IV/IO | not captured | standing | page 204 |
| Opioid overdose | adult | 0.4–4 mg | IN | not captured | standing | page 204 |
| Opioid overdose | peds | 0.1 mg/kg | IN | not captured | standing | pages 25, 87, 204 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 25, 87, 204 |
| Other | adult | 0.1 mg/kg | IV/IO/IN | not captured | standing | pages 25, 87 |
| Other | adult | 0.4–1 mg | IV/IO/IN | not captured | standing | page 203 |
| Other | adult | 0.4–1 mg | IV/IO | not captured | standing | page 189 |
| Other | adult | 0.4–4 mg | IV/IO/IM/IN | not captured | standing | pages 63, 109 |
| Other | adult | 0.5 mg | IV/IO/IM/IN | not captured | standing | page 187 |
| Other | peds | 0.1 mg/kg | IV/IO/IN | not captured | standing | pages 25, 87 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 63, 109 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | pages 45, 205 |
| Other | adult | 0.4 mg | SL | not captured | standing | pages 43, 205 |
| Other | adult | 0.4 mg | SL | not captured | standing | pages 45, 53, 205 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 4–30 mcg/kg | IV/IO | not captured | standing | page 206 |
| Bradycardia | peds | 0.1 mcg/kg | IV/IO | not captured | standing | page 206 |
| Hypotension / shock | adult | 4–30 mcg | IV/IO | not captured | standing | pages 61, 62, 107, 108 |
| Hypotension / shock | peds | 0.1 mcg/kg | IV/IO | not captured | standing | pages 61, 62, 107, 108 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IO/IM/PO | not captured | standing | pages 71, 115, 207 |
| Nausea / vomiting | adult | 4 mg | IV/IO/IM/PO/SL | not captured | standing | page 71 |
| Nausea / vomiting | peds | 0.15 mg/kg | IV/IO/IM/PO | not captured | standing | pages 71, 115, 207 |
| Nausea / vomiting | peds | 0.15 mg/kg | IV/IO/IM/PO | not captured | standing | page 115 |
| Other | adult | 8 mg | IV/IO/IM/IN/PO | not captured | standing | page 127 |
| Other | peds | 0.2 mg/kg | IV/IO/IM/IN/PO | not captured | standing | page 127 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | pages 55, 105 |
| Hypoglycemia | adult | 15–31 g | PO | not captured | standing | pages 55, 105, 177 |
| Hypoglycemia | peds | 15 g | PO | not captured | standing | pages 55, 105 |
| Hypoglycemia | peds | 7.5–15.5 g | PO | not captured | standing | pages 55, 105, 177 |
P–R Plasma, Pralidoxime, Prochlorperazine, Promethazine, Proparacaine, Racemic Epinephrine, Rocuronium7
Plasma
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 unit | IV/IO | not captured | standing | page 221 |
| Other | peds | 1 unit | IV/IO | not captured | standing | page 221 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 600 mg | IM | not captured | standing | pages 151, 152, 182 |
| Organophosphate poisoning | adult | 600 mg | IM | not captured | standing | pages 151, 152, 182 |
| Other | adult | 600 mg | IM | not captured | standing | pages 64, 110, 151, 152, 182 |
Prochlorperazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 5 mg | IV/IM | not captured | standing | page 71 |
| Nausea / vomiting | adult | 5–10 mg | IV/IM | not captured | standing | pages 71, 115, 209 |
| Nausea / vomiting | peds | 0.1–0.15 mg/kg | IV/IM | not captured | standing | pages 71, 115, 209 |
| Other | adult | 5–10 mg | IV | not captured | standing | page 209 |
| Other | peds | 0.1–0.15 mg/kg | IV/IO/IM | not captured | standing | page 115 |
| Other | peds | 0.1–0.15 mg/kg | IV | not captured | standing | page 209 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5–25 mg | IM | not captured | standing | pages 71, 115, 210 |
| Nausea / vomiting | adult | 12.5 mg | IV/IM | not captured | standing | page 71 |
| Nausea / vomiting | peds | 0.25–1 mg/kg | IM | not captured | standing | pages 71, 115, 210 |
| Other | peds | 0.25–1 mg/kg | PO | not captured | standing | page 210 |
| Other | peds | 0.25–1 mg/kg | IV/IO/IM/PO | not captured | standing | page 115 |
Proparacaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Burns | adult | 1–2 drop | OPH | not captured | standing | pages 127, 211 |
| Burns | peds | 1–2 drop | OPH | not captured | standing | pages 127, 211 |
| Other | adult | 1–2 drop | OPH | not captured | standing | pages 127, 211 |
| Other | adult | 1–2 drop | OPH | not captured | standing | pages 127, 211 |
| Other | adult | 2 drop | OPH | not captured | standing | page 127 |
| Other | peds | 1–2 drop | OPH | not captured | standing | pages 127, 211 |
| Other | peds | 1–2 drop | OPH | not captured | standing | pages 127, 211 |
| Other | peds | 2 drop | OPH | not captured | standing | page 127 |
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | peds | 0.5 mL | NEB | not captured | standing | pages 65, 111, 112, 212 |
| Croup | peds | 0.5 mL | NEB | not captured | standing | pages 65, 111, 112, 212 |
| Other | adult | 0.5 mL | NEB | not captured | standing | page 65 |
| Respiratory distress | peds | 0.5 mL | NEB | not captured | standing | pages 65, 111, 112, 212 |
| Stridor | peds | 0.5 mL | NEB | not captured | standing | pages 65, 111, 112, 212 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | page 213 |
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | page 23 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 213 |
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | pages 21, 23, 83, 85, 213 |
| RSI induction | peds | 1 mg/kg | IV/IO | not captured | standing | pages 21, 23, 83, 85, 213 |
S–Z Sodium Bicarbonate, Succinylcholine, Tetracaine, Tranexamic Acid, Vecuronium, Whole Blood6
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 100 mEq | IV/IO | not captured | standing | page 125 |
| Crush injury | peds | 1 mEq/kg | IV/IO | not captured | standing | page 125 |
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 12, 30, 33 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 12, 30, 33 |
| Other | adult | 100 mEq | IV/IO | not captured | standing | page 11 |
| Other | adult | 50 mEq | IV/IO | not captured | standing | pages 31, 32 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | page 109 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | page 214 |
| Tricyclic overdose | adult | 100 mEq | IV/IO | not captured | standing | pages 31, 63, 109 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 31, 63, 109 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 215 |
| Other | peds | 2 mg/kg | IV/IO | not captured | standing | page 215 |
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | pages 21, 83, 215 |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | pages 21, 83, 215 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Burns | adult | 2 drop | OPH | not captured | standing | page 127 |
| Burns | peds | 2 drop | OPH | not captured | standing | page 127 |
| Other | adult | 2 drop | OPH | not captured | standing | page 127 |
| Other | adult | 2 drop | OPH | not captured | standing | page 127 |
| Other | adult | 2 drop | OPH | not captured | standing | page 127 |
| Other | peds | 2 drop | OPH | not captured | standing | page 127 |
| Other | peds | 2 drop | OPH | not captured | standing | page 127 |
| Other | peds | 2 drop | OPH | not captured | standing | page 127 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV/IO | not captured | standing | page 117 |
| Other | adult | 1 g | IV | not captured | standing | page 216 |
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | pages 117, 216 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 217 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 217 |
| RSI induction | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 21, 23, 83, 85, 217 |
| RSI induction | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 21, 23, 83, 85, 217 |
Whole Blood
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 unit | IV/IO | not captured | standing | page 221 |
| Other | peds | 1 unit | IV/IO | not captured | standing | page 221 |
Change history1
| Recorded | Change | From | To |
|---|---|---|---|
| 2026-10-31 | added | not captured | listed_named |
Cite this
State of Nebraska, United States EMS Protocol Census. 325 dose entries, effective 2024-09-09.
https://protoquiz.com/census/agencies/state-of-nebraska/
The census is free and not for sale. Only public agencies are named.